{{Rsnum
|rsid=6556412
|Gene=FBXO44
|Chromosome=5
|position=159360377
|Orientation=plus
|GMAF=0.3811
|Gene_s=FBXO44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 42.5 | 46.9
| HCB | 16.1 | 47.4 | 36.5
| JPT | 24.8 | 43.4 | 31.9
| YRI | 8.2 | 46.9 | 44.9
| ASW | 12.3 | 31.6 | 56.1
| CHB | 16.1 | 47.4 | 36.5
| CHD | 22.0 | 49.5 | 28.4
| GIH | 15.8 | 46.5 | 37.6
| LWK | 30.9 | 51.8 | 17.3
| MEX | 19.0 | 34.5 | 46.6
| MKK | 21.3 | 51.0 | 27.7
| TSI | 13.7 | 49.0 | 37.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=21102463
  |Trait=Crohn's disease
  |Title=Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
  |RiskAllele=A
  |Pval=5E-14
  |OR=1.18
  |ORtxt=[1.13-1.24]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}